Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Capitol Connections Article FDA Reclassifies Hydrocodone 11.1.13
Share |

FDA Supports Hydrocodone Move to C-II

Yesterday, the Food and Drug Administration formally proposed that all hydrocodone containing medications be reclassified to Schedule II status. Dr. Janet Woodcock, director of the agency’s Center for Drug Evaluation and Research, said she expected the new regulations to go into effect in 2014.The recommendation requires the approval of the Department of Health and Human Services and adoption by the Drug Enforcement Administration, which has long pushed for the measure. This announcement comes on the heels of a recommendation from an FDA’s expert advisory panel that voted 19 to 10 in favor of the reclassification earlier this year. Click here to read more from the FDA.

Association Management Software Powered by YourMembership  ::  Legal